Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Josep M, Grinyo"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Obbo W. Bredewold, MD, Joe Chan, My Svensson, Annette Bruchfeld, Johan W. de Fijter, Hans Furuland, Josep M. Grinyo, Anders Hartmann, Hallvard Holdaas, Olof Hellberg, Alan Jardine, Lars Mjörnstedt, Karin Skov, Knut T. Smerud, Inga Soveri, Søren S. Sørensen, Anton-Jan van Zonneveld, Bengt Fellström
Publikováno v:
Kidney Medicine, Vol 5, Iss 1, Pp 100574- (2023)
Rationale & Objective: In kidney transplant recipients (KTRs), a belatacept-based immunosuppressive regimen is associated with beneficial effects on cardiovascular (CV) risk factors compared with calcineurin inhibitor (CNI)–based regimens. Our obje
Externí odkaz:
https://doaj.org/article/c79dbfeee8274a49bb87981258c2c2b4
Autor:
Miguel Hueso, Laura De Ramon, Estanislao Navarro, Elia Ripoll, Josep M. Cruzado, Josep M. Grinyo, Joan Torras
Publikováno v:
Data in Brief, Vol 9, Iss C, Pp 1105-1112 (2016)
Data presented in this Data in Brief article correspond to the article "in vivo" silencing of CD40 reduces progression of experimental atherogenesis through a NFκB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclero
Externí odkaz:
https://doaj.org/article/035470eff9b3476683396c75ec8c0f67
Autor:
Ana Merino, Elia Ripoll, Laura De Ramon, Nuria Bolaños, Montserrat Goma, Oriol Bestard, Nuria Lloberas, Josep M. Grinyo, Juan Torras Ambròs
Publikováno v:
Cell Transplantation, Vol 26 (2017)
The immunomodulatory characteristics of mesenchymal stromal cells (MSCs) may lead to multifaceted strategies in rejection of organ transplantation. This study was designed to investigate, first, the effect of the donor-type MSCs from Wistar rats on t
Externí odkaz:
https://doaj.org/article/e4d25abca7c54b66a6ab7de7057ae6f3
Autor:
Fernanda Ortiz, Rosana Gelpi, Ilkka Helanterä, Edoardo Melilli, Eero Honkanen, Oriol Bestard, Josep M Grinyo, Josep M Cruzado
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159717 (2016)
The pros and cons for implementing protocol biopsies (PB) after kidney transplantation are still a matter of debate. We aimed to address the frequency of pathological findings in PB, to analyze their impact on long-term graft survival (GS) and to ana
Externí odkaz:
https://doaj.org/article/f5e5d1626dbc426394ab383e16b789d1
Autor:
Obbo W. Bredewold, Joe Chan, My Svensson, Annette Bruchfeld, Johan W. Fijter, Hans Furuland, Josep M. Grinyo, Anders Hartmann, Hallvard Holdaas, Olof Hellberg, Alan Jardine, Lars Mjörnstedt, Karin Skov, Knut T. Smerud, Inga Soveri, Sören S. Sörensen, Anton-Jan Zonneveld, Bengt Fellstrom
In renal transplant recipients (RTRs), a belatacept-based immunosuppressive regimen is associated with beneficial effects on cardiovascular (CV) risk factors compared with calcineurin inhibitor (CNI)-based regimens. The aim of this randomized, multi-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eac222c1e58682c102b6e3108952dd8
https://doi.org/10.21203/rs.3.rs-1283060/v1
https://doi.org/10.21203/rs.3.rs-1283060/v1
Autor:
Josep M, Grinyo
Publikováno v:
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 20(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a22a8a19a8cbc0743f922349c61729b1
https://pubmed.ncbi.nlm.nih.gov/19237802
https://pubmed.ncbi.nlm.nih.gov/19237802
Publikováno v:
Contributions to nephrology. 159
Thanks to the progressive understanding of the cellular and molecular basis of renal function and disease, during the next several decades new therapeutic approaches to a wide range of kidney disorders, including acute renal failure (ARF), will be de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::efd8fb2e55a4a77462c56a907df70a2d
https://pubmed.ncbi.nlm.nih.gov/18391587
https://pubmed.ncbi.nlm.nih.gov/18391587
Publikováno v:
Transplantation. 74(11)
Sirolimus (Rapamune; SRL) in combination with cyclosporine (CsA) reduces the incidence of acute rejection episodes in renal allograft recipients. This study evaluated whether renal function could be improved by elimination of CsA from an SRL-based re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dcbe1b0f589fd349d9e50129b77697ad
https://pubmed.ncbi.nlm.nih.gov/12490789
https://pubmed.ncbi.nlm.nih.gov/12490789